136 related articles for article (PubMed ID: 30326074)
1. Dark Spot in Fibrinous Central Serous Chorioretinopathy.
Singh SR; Dogra M; Dogra MR
JAMA Ophthalmol; 2018 Oct; 136(10):e182924. PubMed ID: 30326074
[No Abstract] [Full Text] [Related]
2. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography.
De Bats F; Cornut PL; Wolff B; Kodjikian L; Mauget-Faÿsse M
Eur J Ophthalmol; 2018 Jul; 28(4):446-453. PubMed ID: 29554817
[TBL] [Abstract][Full Text] [Related]
3. Dark spot in fibrinous central serous chorioretinopathy masquerading choroiditis.
Parchand S; Gupta V; Gupta A; Dogra MR; Singh R; Sharma A
Ocul Immunol Inflamm; 2013 Jun; 21(3):201-6. PubMed ID: 23472760
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
5. Value of three-dimensional optical coherence tomography and fundus photochromy in correlating the fluorescein leaking sites of acute central serous chorioretinopathy.
Wang GH; Zhang J; Zhang D; Lv FL; Wang LX
Med Princ Pract; 2011; 20(3):283-6. PubMed ID: 21455001
[TBL] [Abstract][Full Text] [Related]
6. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and therapeutic challenges.
Gupta OP; Garg SJ; Negrey JN; Jahnle R; Pasion R; Ip MS; Hwang FS; Kaines A; Jain AK; Schwartz SD
Retina; 2010 Jun; 30(6):975-80. PubMed ID: 20531147
[No Abstract] [Full Text] [Related]
8. Central Serous Chorioretinopathy.
Daruich A; Matet A; Behar-Cohen F
Dev Ophthalmol; 2017; 58():27-38. PubMed ID: 28351043
[TBL] [Abstract][Full Text] [Related]
9. Photopigments in central serous chorioretinopathy.
Ojima A; Iida T; Sekiryu T; Maruko I; Sugano Y
Am J Ophthalmol; 2011 Jun; 151(6):940-952.e1. PubMed ID: 21457927
[TBL] [Abstract][Full Text] [Related]
10. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
Koytak A; Erol K; Coskun E; Asik N; Öztürk H; Özertürk Y
Retina; 2010; 30(10):1698-703. PubMed ID: 20539254
[TBL] [Abstract][Full Text] [Related]
11. Central Serous Chorioretinopathy in a Patient with Ectopic Adrenocorticotropic Hormone-secreting Tumor.
Chen KJ; Wang NK; Shen JH
Ophthalmology; 2017 Jun; 124(6):821. PubMed ID: 28528827
[No Abstract] [Full Text] [Related]
12. Central serous chorioretinopathy in young adults.
Pryds A; Larsen M; Barbazetto I; Yannuzzi L
Acta Ophthalmol; 2012 Aug; 90(5):e404-5. PubMed ID: 23043628
[No Abstract] [Full Text] [Related]
13. Central serous chorioretinopathy in myopic patients.
Yzer S; Fung AT; Barbazetto I; Yannuzzi LA; Freund KB
Arch Ophthalmol; 2012 Oct; 130(10):1339-40. PubMed ID: 23044956
[No Abstract] [Full Text] [Related]
14. Expanding the OCT Spectrum of Acute Central Serous Chorioretinopathy: The Stalagmite-Stalactite Pattern.
Ramtohul P; Comet A; Denis D
Ophthalmol Retina; 2019 Aug; 3(8):636. PubMed ID: 31383396
[No Abstract] [Full Text] [Related]
15. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
Lee H; Lee J; Chung H; Kim HC
Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
[TBL] [Abstract][Full Text] [Related]
16. Masqueraders of central serous chorioretinopathy.
Sahoo NK; Singh SR; Rajendran A; Shukla D; Chhablani J
Surv Ophthalmol; 2019; 64(1):30-44. PubMed ID: 30243734
[TBL] [Abstract][Full Text] [Related]
17. [Bilateral abnormalities in central serous chorioretinopathy seen in optical coherence tomography, ultra-widefield fluorescein angiography and microperimetry--case report].
Tylus M; Święch-Zubilewicz A; Dolar-Szczasny J; Mackiewicz J
Klin Oczna; 2015; 117(3):173-6. PubMed ID: 26999941
[TBL] [Abstract][Full Text] [Related]
18. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
Dysli C; Berger L; Wolf S; Zinkernagel MS
Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
[TBL] [Abstract][Full Text] [Related]
19. Outcome of a fibrinous exudation in fibrinous central serous chorioretinopathy. The "Y" sign.
Sánchez-Sevila JL; Rodrigo-Auria F
Arch Soc Esp Oftalmol (Engl Ed); 2019 Sep; 94(9):e66. PubMed ID: 31151688
[No Abstract] [Full Text] [Related]
20. Spectral domain optical coherence tomography predates fluorescein angiography in diagnosing central serous chorioretinopathy.
Gupta V; Gupta A; Gupta P
Indian J Ophthalmol; 2010; 58(2):173-5. PubMed ID: 20195055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
